1. An integrative pan-cancer analysis of COPB1 based on data mining
   Heyan Chen et al, 2021, Cancer Biomarkers CrossRef
2. Metformin in breast cancer: preclinical and clinical evidence
   Anindita De et al, 2020, Current Problems in Cancer CrossRef
3. Synergistic effect of antimetabolic and chemotherapy drugs in triple-negative breast cancer
   Elena López-Camacho et al, 2022, Biomedicine & Pharmacotherapy CrossRef
4. 2-Deoxy-D-glucose increases the sensitivity of glioblastoma cells to BCNU through the regulation of glycolysis, ROS and ERS pathways: In vitro and in vivo validation
   Xiaodong Sun et al, 2022, Biochemical Pharmacology CrossRef
5. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors
   Claire Muller et al, 2024, Cancer Cell International CrossRef
6. Novel mutation in hexokinase 2 confers resistance to 2-deoxyglucose by altering protein dynamics
   Erich Hellemann et al, 2022, PLOS Computational Biology CrossRef
7. Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis
   J. R. Dev Arundhathi et al, 2021, Molecular Biology Reports CrossRef
8. The LC-MS/MS Identification and Analgesic and Wound Healing Activities of Lavandula officinalis Chaix: In Vivo and In Silico Approaches
   Meryem Slighoua et al, 2022, Plants CrossRef
9. Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells
   Nethaji Muniraj et al, 2019, Carcinogenesis CrossRef
10. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors
    Yangke Wanyan et al, 2020, Molecules CrossRef
11. LC-MS/MS and GC/MS Profiling of Petroselinum sativum Hoffm. and Its Topical Application on Burn Wound Healing and Related Analgesic Potential in Rats
    Meryem Slighoua et al, 2023, Metabolites CrossRef
12. A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines
    Sheree D. Martin et al, 2019, Cancer & Metabolism CrossRef
13. Metabolic changes in tumor cells and tumor-associated macrophages: A mutual relationship
    Romana T. Netea-Maier et al, 2018, Cancer Letters CrossRef
14. Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness
    Mayumi Fujita et al, 2020, BMC Cancer CrossRef
15. Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cells
    Jernej Repas et al, 2021, Scientific Reports CrossRef
16. Mitochondrial targeting theranostic nanomedicine and molecular biomarkers for efficient cancer diagnosis and therapy
    Susanta Kumar Rout et al, 2022, Biomedicine & Pharmacotherapy CrossRef
17. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
    Julieta Afonso et al, 2020, Nature Reviews Urology CrossRef
18. Metformin and Breast Cancer: Where Are We Now?
    Mónica Cejuela et al, 2022, International Journal of Molecular Sciences CrossRef
19. Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells
    Friederike Steifensand et al, 2021, Cells CrossRef
20. An Arthropod Hormone, Ecdysterone, Inhibits the Growth of Breast Cancer Cells via Different Mechanisms
    O. Shuvalov et al, 2020, Frontiers in Pharmacology CrossRef
21. Starvation stress attenuates the miRNA-target interaction in suppressing breast cancer cell proliferation
    Jinhui Lü et al, 2020, BMC Cancer CrossRef
22. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
    Kalpana Tilekar et al, 2020, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
23. Glucose deprivation reduces proliferation and motility, and enhances the anti-proliferative effects of paclitaxel and doxorubicin in breast cell lines in vitro
    Maitham A. Khajah et al, 2022, PLOS ONE CrossRef
24. Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
    Samson Samuel et al, 2019, Biomolecules CrossRef
25. A Tumor Agnostic Therapeutic Strategy for Hexokinase 1–Null/Hexokinase 2–Positive Cancers
    Shili Xu et al, 2019, Cancer Research CrossRef
26. Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors
    Xueyan Sun et al, 2021, Bioorganic Chemistry CrossRef